Rankings
▼
Calendar
CORT Q4 2016 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena
CORT
Corcept Therapeutics Incorporated
$4B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
Gross Profit
$23M
97.6% margin
Operating Income
$5M
21.0% margin
Net Income
$5M
19.3% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
+9.6%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$69M
Total Liabilities
$27M
Stockholders' Equity
$41M
Cash & Equivalents
$52M
← FY 2016
All Quarters
Q1 2017 →
